da Silva Barcelos L, Ford A, Fruhauf M, Botton N, Fischer G, Maggioli M
Viruses. 2024; 16(11).
PMID: 39599867
PMC: 11598946.
DOI: 10.3390/v16111753.
Kitai Y, Watanabe O, Ohmiya S, Kisu T, Ota R, Kawakami K
Sci Rep. 2024; 14(1):11823.
PMID: 38783052
PMC: 11116427.
DOI: 10.1038/s41598-024-62658-z.
Le Rouzic A, Fix J, Vinck R, Kappler-Gratias S, Volmer R, Gallardo F
Int J Mol Sci. 2024; 25(1).
PMID: 38203585
PMC: 10778932.
DOI: 10.3390/ijms25010415.
Huynh H, Levitz R, Huang R, Kahn J
Sci Rep. 2021; 11(1):24442.
PMID: 34952911
PMC: 8709853.
DOI: 10.1038/s41598-021-03814-7.
Blunck B, Aideyan L, Ye X, Avadhanula V, Ferlic-Stark L, Zechiedrich L
Vaccine. 2021; 40(3):536-543.
PMID: 34903371
PMC: 8755595.
DOI: 10.1016/j.vaccine.2021.11.087.
Mechanism of Cross-Resistance to Fusion Inhibitors Conferred by the K394R Mutation in Respiratory Syncytial Virus Fusion Protein.
Tang W, Li Y, Song Q, Wang Z, Li M, Zhang Q
J Virol. 2021; 95(20):e0120521.
PMID: 34379500
PMC: 8475503.
DOI: 10.1128/JVI.01205-21.
Inactivation of Replication-Competent Vesicular Stomatitis Virus as SARS-CoV-2 Surrogate on Common Surfaces by Disinfectants.
Pope Z, Kottke T, Shah A, Vile R, Rizza S
Int J Environ Res Public Health. 2021; 18(14).
PMID: 34300163
PMC: 8304672.
DOI: 10.3390/ijerph18147714.
Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes.
Malogolovkin A, Gasanov N, Egorov A, Weener M, Ivanov R, Karabelsky A
Viruses. 2021; 13(7).
PMID: 34209981
PMC: 8309967.
DOI: 10.3390/v13071271.
Engineering of Live Chimeric Vaccines against Human Metapneumovirus.
Ogonczyk Makowska D, Hamelin M, Boivin G
Pathogens. 2020; 9(2).
PMID: 32093057
PMC: 7168645.
DOI: 10.3390/pathogens9020135.
Alternative conformations of a major antigenic site on RSV F.
Jones H, Battles M, Lin C, Bianchi S, Corti D, McLellan J
PLoS Pathog. 2019; 15(7):e1007944.
PMID: 31306469
PMC: 6658013.
DOI: 10.1371/journal.ppat.1007944.
RSV Vaccine Based on Rhabdoviral Vector Protects after Single Immunization.
Wilmschen S, Schneider S, Peters F, Bayer L, Issmail L, Banki Z
Vaccines (Basel). 2019; 7(3).
PMID: 31277325
PMC: 6790003.
DOI: 10.3390/vaccines7030059.
Dichloro-Phenyl-Benzotriazoles: A New Selective Class of Human Respiratory Syncytial Virus Entry Inhibitors.
Piras S, Sanna G, Carta A, Corona P, Ibba R, Loddo R
Front Chem. 2019; 7:247.
PMID: 31041309
PMC: 6476926.
DOI: 10.3389/fchem.2019.00247.
Respiratory syncytial virus entry and how to block it.
Battles M, McLellan J
Nat Rev Microbiol. 2019; 17(4):233-245.
PMID: 30723301
PMC: 7096974.
DOI: 10.1038/s41579-019-0149-x.
The Heptad Repeat C Domain of the Respiratory Syncytial Virus Fusion Protein Plays a Key Role in Membrane Fusion.
Bermingham I, Chappell K, Watterson D, Young P
J Virol. 2017; 92(4).
PMID: 29212939
PMC: 5790940.
DOI: 10.1128/JVI.01323-17.
Application of replication-defective West Nile virus vector to non-flavivirus vaccine targets.
Giel-Moloney M, Vaine M, Zhang L, Parrington M, Gajewska B, Vogel T
Hum Vaccin Immunother. 2017; 13(12):2982-2986.
PMID: 28925795
PMC: 5718821.
DOI: 10.1080/21645515.2017.1373920.
Paramyxovirus Glycoproteins and the Membrane Fusion Process.
Aguilar H, Henderson B, Zamora J, Johnston G
Curr Clin Microbiol Rep. 2017; 3(3):142-154.
PMID: 28138419
PMC: 5270710.
DOI: 10.1007/s40588-016-0040-8.
Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment.
Clarke D, Hendry R, Singh V, Rose J, Seligman S, Klug B
Vaccine. 2016; 34(51):6597-6609.
PMID: 27395563
PMC: 5220644.
DOI: 10.1016/j.vaccine.2016.06.071.
Identification of a Human Respiratory Syncytial Virus Cell Entry Inhibitor by Using a Novel Lentiviral Pseudotype System.
Haid S, Grethe C, Bankwitz D, Grunwald T, Pietschmann T
J Virol. 2016; 90(6):3065-73.
PMID: 26719246
PMC: 4810627.
DOI: 10.1128/JVI.03074-15.
Respiratory syncytial virus fusion protein promotes TLR-4-dependent neutrophil extracellular trap formation by human neutrophils.
Funchal G, Jaeger N, Czepielewski R, Machado M, Muraro S, Stein R
PLoS One. 2015; 10(4):e0124082.
PMID: 25856628
PMC: 4391750.
DOI: 10.1371/journal.pone.0124082.
Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics.
Pfaller C, Cattaneo R, Schnell M
Virology. 2015; 479-480:331-44.
PMID: 25702088
PMC: 4557643.
DOI: 10.1016/j.virol.2015.01.029.